Tracvirus SafeTravelPass (“My Travel Pass”, “My Safe Travel” or “E-Cert”) for Malaysia inbound travellers Covid-19 screening test and quarantine payment, QR Code E-Cert and mobile application one stop solution

7 September 2020, Kuala Lumpur : In conjunction to joint launching of Tracvirus E-Cert with Malaysia Tourism Council (MTC) in July 2020, Tri-G Technologies Sdn Bhd, the official service provider of Tracvirus Open Platform in Malaysia launches Malaysia Tracvirus SafeTravelPass for inbound travellers Covid-19 screening test and quarantine payment, QR Code E-Cert and mobile application today.

First of its kind worldwide, the beta version of Tracvirus E-Cert was submitted to Ministry of Health (“MOH”), Majlis Keselamatan Negara (“MKN”), for government use. The platform which is already in use by laboratories and clinics in Malaysia, came with mobile application which is downloadable in Google Android phones or Apple Iphone.

The Tracvirus Open Platform is developed by Medic Data Science Ltd (“MDS”), and licensed to Tri-G Technologies Sdn Bhd (“TRI-G”) for the use in Malaysia. The platform’s “SafeTravelPass” system is developed for Ministry of Health and government agencies Covid-19 screening test and quarantine payment for all national borders, inbound and outbound travellers, either airport, seaport or borders. The Tracvirus application and e-certificates came with QR Code recognised worldwide. Tracvirus Open Platform came with secured user privacy and third party data access protection, hosted by International cloud servers and mirrors in Malaysia, Indonesia, China, and USA. 

Tracvirus Lab System is solely controlled by respective countries’ Health Ministry approved laboratories, where sample test and reports are using QR Code directly update by labs to relevant government system without third party access, while separately delivered to lab or clinics end users in real-time. The process flow is first in the world to use unified E-Certification and licensed by licensees worldwide since the start of the Covid-19 Pandemic.

Tracvirus SafeTravelPass is available worldwide, and license or private label is API is available for respective country Ministry of Health accredited laboratory or government approved medical device providers.

Travellers to Malaysia can apply for Tracvirus SafeTravelPass or “My Safe Travel” or “My Travel Pass” at: https://safetravelpass.tracvirus.com.my


About Tracvirus E-Certificate (“E-Cert”)

Tracvirus E-Certificate or private labeled as “SafeTravelPass”, “My Travel Pass”, or “My Safe Travel” (collectively “E-Cert”), was launched and in use in Malaysia and Indonesia since July 2020, together with Malaysia Tourism Council (MTC), and accepted by government of Malaysia to be use by Ministry of Health (MOH) and other government agencies. The Tracvirus Open Platform is developed by Medic Data Science Ltd (“MDS”), and licensed to Tri-G Technologies Sdn Bhd (“TRI-G”) for the use in Malaysia. The platform’s “SafeTravelPass” system is developed for Ministry of Health and government agencies Covid-19 screening test and quarantine payment for all national borders, inbound and outbound travellers, either airport, seaport or borders. The Tracvirus application and e-certificates came with QR Code recognised worldwide. Tracvirus Open Platform came with secured user privacy and third party data access protection, hosted by International cloud servers and mirrors in Malaysia, Indonesia, China, and USA. Tracvirus Lab System is solely controlled by respective countries’ Health Ministry approved laboratories, where sample test and reports are using QR Code directly update by labs to relevant government system without third party access, while separately delivered to lab or clinics end users in real-time. The process flow is first in the world to use unified E-Certification and licensed by licensees worldwide since the start of the Covid-19 Pandemic.

RSUI Jalin Kerja Sama dengan HIPTEK dalam Pelayanan Pemeriksaan RT-PCR Covid-19 – [19 Aug 2020]

BEPOK, Jakarta, Indonesia – Rumah Sakit Universitas Indonesia (RSUI) menjalin kerja sama dengan Himpunan Pemeriksa Tenaga Kesehatan Indonesia (HIPTEK) dalam pelaksanaan pelayanan pemeriksaaan real time polymerase chain reaction (RT-PCR) Covid-19.

Kesepakatan tersebut ditandai dengan penandatanganan Perjanjian Kerja Sama (PKS) yang dilakukan oleh Direktur Utama RSUI, dr. Astuti Giantini, Sp PK MPH dan Ketua Umum HIPTEK, dr Tahir Abdulkadir.

Penandatanganan yang disaksikan oleh jajaran Dewan Pimpinan Pusat HIPTEK dan jajaran Direksi serta Manajemen RSUI ini dilakukan pada Rabu (19/8/2020) di Auditorium Gedung Administrasi RSUI, Kampus UI, Depok.

Ruang lingkup perjanjian ini adalah pengadaan kerja sama dalam hal pemeriksaan Real Time Polymerase Chain Reaction (RT-PCR) bagi Calon Pekerja Migran Indonesia (CPMI), masyarakat umum, dan calon jemaah umrah serta haji melalui Sarana Kesehatan Anggota HIPTEK.

Tahir menyampaikan bahwa penandatanganan kerja sama dengan RSUI ini dilakukan sebagai bentuk komitmen HIPTEK dalam mengawal Undang-undang Republik Indonesia Nomor 18 Tahun 2017 tentang Perlindungan Pekerja Migran Indonesia dan Keputusan Menteri Ketenagakerjaan RI Nomor 294 Tahun 2020 tentang Pelaksanaan Penempatan Pekerja Migran Indonesia Pada Masa Adaptasi Kebiasaan Baru. 

“Berdasarkan amanah Undang-undang tersebut, kami siap melayani Calon Pekerja Migran Indonesia (CPMI) yang akan bekerja ke luar negeri pada masa adaptasi kebiasaan baru (AKB) dengan pemeriksaan Swab PCR, yang mana pengambilan spesimen swab tetap dilakukan di Klinik Utama anggota HIPTEK. Namun untuk pemeriksaannya kita serahkan ke Rumah Sakit Rujukan COVID, yaitu RSUI.” ujar Tahir.

Sementara dalam sambutannya,  Astusti menuturkan “RSUI sebagai salah satu rumah sakit yang melayani pemeriksaan COVID-19, tentunya sangat siap dan bersyukur dapat dipercaya untuk menerima rujukan spesimen swab dari Klinik Utama anggota HIPTEK, ujar  Astuti.

“Bahan yang akan diperiksa (sampel) atau bahan yang belum siap diperiksa (spesimen) nanti akan dilakukan pemeriksaan oleh tenaga kesehatan kami yang sudah terlatih di sini. Kami tentunya akan bekerja semaksimal mungkin untuk dapat memberikan hasil pemeriksaan yang akurat dan cepat sehingga dapat memenuhi kebutuhan jejaring anggota Hiptek,” tambah Astuti.

Bersamaan dengan acara tersebut, sebagai salah satu bentuk implementasi kerja sama dalam menunjang tersedianya perangkat pemeriksaan SARS CoV-2 (Covid-19), antara Direktur Utama RSUI, dr Astuti Giantini, Sp PK MPH dan Presiden Direktur PT. NDS Global Teknologi, Devi Erna Rachmawati, SE MBA PhD,  juga menandatangani Perjanjian Kerja Sama (PKS) tentang “Program Konsinyasi Pemeriksaan SARS CoV-2 (Covid-19)”.

Ruang lingkup kerja sama tersebut meliputi penempatan set perangkat RT-PCR yang bekerja sama dengan Nexgram Biomedics, Sdn Bhd; pelatihan teknik pengambilan swab kepada Klinik Utama anggota HIPTEK; pemeriksaan Swab PCR menggunakan set perangkat RT-PCR yang memiliki kapasitas 1000 pemeriksaan per hari dengan hasil kurang dari 24 jam; dan penggunaan aplikasi Tracvirus yang berfungsi untuk memonitor dan merekam secara online maupun sistematis.

Aplikasi ini mengeluarkan E-Cert (sertifikasi online) yang dapat memastikan tidak terjadi pemalsuan dan penipuan sertifikat pemeriksaan COVID-19.

Kerja sama ini dilakukan atas dasar komitmen kedua belah pihak untuk dapat memberikan pelayanan kesehatan melalui tata kelola yang profesional, komprehensif, dan terpadu.

Selain itu, RSUI berharap adanya kerja sama dengan HIPTEK ini merupakan wujud kepedulian yang berdampak baik bukan hanya untuk organisasi tetapi juga dapat melindungi masyarakat sekitar lingkungan organisasi yang memiliki potensi penularan Covid-19 dengan cepat.

Source: https://wartakota.tribunnews.com/2020/08/19/rsui-jalin-kerja-sama-dengan-hiptek-dalam-pelayanan-pemeriksaan-rt-pcr-covid-19

Nexgram and Malaysian Tourism Council enrol Tracvirus Covid-19 Test for 3.5 million workers [23 July 2020] Press Release

23 July 2020, Kuala Lumpur – Tracvirus E-Cert provides tourism industry Covid-19 test with a sense of safety and confidence. Tracvirus is developed by Tri-G Technologies Sdn Bhd (TRI-G), a subsidiary of Bursa Malaysia listed Nexgram Holdings Berhad. Together with Malaysian Tourism Council, Tri-G launched the Covid-19 test campaign to service 3.5 million tourism workers today.

TRI-G is a company registered with the Medical Device Authority (MDA), supplying medical equipment to government and private hospitals, as well as authorized distributor for Covid-19 PCR test and RTK antibody test kits approved by Ministry of Health (MOH), including International brands such as Healgen and Liangrun.

The current Covid-19 pandemic that has hit the world has affected every sector in the country’s economic, especially the tourism industry. After more than four months of the Covid-19 crisis with series of movement restrictions, the tourism industry is now expected to recover after the government announced the Restoration Movement Control Order (PKPP) which allows the domestic tourism sector to reopen.

To ensure that the tourism sector is able to generate economic growth and build confidence among tourists, Nexgram via its subsidiary TRI-G together with the Malaysian Tourism Council have agreed to establish strategic cooperation.

“The industry effort is to ensure that employees, especially front liners such as reception, f & b, and housekeeping are always free from Covid-19 and do not create new cluster”, commented Malaysian Tourism Council spoke person.

Tracvirus platform provides easy access to a network of over 5000 clinics and MOH-accredited laboratories nationwide, with the ability to provide various types of Covid-19 tests for tourists and tourism industry stakeholders, unified all test reports under one E-Certification format.

The online Covid-19 test monitoring and control system can be access online through TRACVIRUS.COM. Every individual who has been screened whether using the PCR or RTK can be systematically recorded online, and an E-Cert is issued as proof of test. “This is the first online system of its kind developed in Malaysia by local talent and we are also working with Google to pioneer this application not only in our country but also in Indonesia and other countries”, according to Tri-G spoke person.

With the availability of Tracvirus, the test history of each individual can be recorded to facilitate the access to accurate and authentic user test reports via QR code scan.

“With such a program being done within the industry player, we believe tourist will be confidence to travel and enjoy their vacation calmly and comfortably”, according to Tri-G spoke person.

In addition, this program acts to ensure that the frontliners of the tourism industry will be safe and protected from Covid-19. Through Tracvirus, it can ensure employers in the tourism industry from the risk of forgery and fraud of Covid-19 test certificates.

As a result of the implementation of this program, Malaysian Tourism Council hope to help the recovery of the tourism sector by ensuring a safe environment to encourage more tourists.

ABOUT NEXGRAM HOLDINGS BHD

NEXGRAM HOLDINGS BERHAD is listed on the ACE Market of Bursa Malaysia Exchange and its headquarter is in Malaysia. The group is a diversified investment company having businesses in IT, security and surveillance, logistics, property and other industries.

ABOUT TRI-G TECHNOLOGIES SDN BHD

Tri-G is a MDA licensed medical supplies distributor with GDPMD certificate in Malaysia. The company is in collaboration with a network of more than 5,000 medical providers nationwide

Tracvirus : One Covid-19 Test and Vaccine Record System, hosting all clinics and labs reports, under unified anti-fraud and anti-fake E-Cert

Tracvirus anti-counterfeiting technology is designed for rapid implementation and came with layered watermark, biometric face recognition-ready, and blockchain equivalent QR Code technology to verify E-Certificate authenticity, in print or digital format. 

Using the Tracvirus E-Cert platform, border traffic control are provided with a unique high-security multi-layered marking incorporate in each E-Cert, while visitors can download an app via Google Play or the App Store that provides the ability to scan and confirm authenticity of another E-Cert, as well as a worldwide track and trace solution with real-time reports to track each individual test status, and flag any counterfeits in the process.

COVID Test & Vaccine is easily Tested, Checked & Verified by Doctors, Employers, Airport, Port, Border Control, State Agencies & Law Enforcement.

Tracvirus is developed by Tri-G Technologies, using MDS Open Platform. To connect and provide Tracvirus E-Certificate in your country, hospital, clinic, or organisation, click here to contract our local representative.